Get the 2025 update on the biotech companies Labiotech spotlighted in 2024 — who advanced, who stalled, and who surprised us.

Comparative assessments and other editorial opinions are those of U.S. News and have not been previously reviewed, approved ...

Apellis Pharmaceuticals has made pipeline progress and strengthened its balance sheet. Click here to read an analysis of APLS ...

Singapore is rapidly emerging as Asia’s leading biotech hub, attracting global pharmaceutical and biotech firms with its political neutrality, strong IP protect ...

MOSCOW (Reuters) -Moscow-based biotech firm R-Pharm International has sued Raiffeisen's Russian unit for 337.5 million euros ...

The Roanoke region’s biotechnology efforts are getting another boost with the announcement Tuesday of a new four-year program ...

BUDAPEST (Reuters) -Higher U.S. tariffs may make it challenging for Hungarian pharmaceutical company Richter to export some products to the United States, but they won't apply to its flagship ...

Trade show directors, whose job is to facilitate business between retailers and manufacturers, are seeing the impact play out ...

Designed by Sylvia Richards, the mass-timber addition to Adimab's Lebanon campus is sensitive to the lushly forested wetland ...

What are Ramblings? Ramblings are a collection of short items that have caught our attention for one reason or another.

Exchange-traded funds are soaring in popularity amid huge returns for some, but investors favour the big guns. Find out which ...

ICON Public Limited Company is still off its highs and has some absolute valuation appeal. Click here to see why ICLR stock ...